Filing Flows › Health Care › Align Technology (ALGN)
Align Technology (ALGN) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Align Technology (ALGN) Q3 2026 earnings results →
Q3 2026 Revenue up 2% year over year to $1.0B · 13¢ of every $1 of revenue kept as net profit · operating margin 16.7%
Align Technology made $1.0B in Q3 2026 (+2% Y/Y). Operating margin 16.7%, net earnings $135M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.0B in Q3 2026, up 2% year over year and down 4% from the previous quarter.
Gross margin was 68.7%, up 4.5 points from Q3 2025. Operating profit was $0.17B, a 16.7% margin (up 7.0 points year over year). Of the extra revenue versus Q3 2025, 382% reached operating profit, above the 10% margin then. Operating expenses fell 3% while revenue rose 2%. Net earnings were $0.14B, up 138% year over year. The effective tax rate was 20.6%.
Operating cash flow was $0.18B (down 3% year over year), 135% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items used $0.03B. Capital expenditures of $0.05B left free cash flow of $0.14B.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $1.0B | +2% | 16.7% | $135M | $183M |
| Q2 2026 | 10-Q | Aug 5, 2026 | $1.1B | +4% | 14.6% | $108M | $193M |
| Q1 2026 | 10-Q | May 6, 2026 | $1.0B | +6% | 13.6% | $113M | $151M |
| Q4 2025 | 10-K | Feb 27, 2026 | $1.0B | +5% | 14.8% | $136M | $223M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $996M | +2% | 9.7% | $56.8M | $189M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $1.0B | -2% | 16.1% | $125M | $129M |
| Q1 2025 | 10-Q | May 8, 2025 | $979M | -2% | 13.4% | $93.2M | $52.7M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Buys from
About Align Technology
Align Technology, Inc. (“we,” “us,” “our,” “Align” or the “Company”) is a global medical device company primarily engaged in the design, manufacture and marketing of Invisalign ® clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (“GPs”), Vivera TM retainers for retention, iTero TM intraoral scanners and services for dentistry, and exocad TM computer-aided design and computer-aided manufacturing (“CAD/CAM”) software for dental laboratories and dental practitioners. Our vision and strategy is to revolutionize orthodontic and restorative dentistry through digital treatment planning and implementation using the Align TM Digital Platform, an integrated suite of proprietary technologies and services designed to deliver a seamless, end-to-end solution for patients, consumers, orthodontists, GPs and lab partners.
In its own words, from its 10-K, filed Feb 27, 2026.
Align Technology against its Orthopedic, Prosthetic & Surgical Appliances & Supplies peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +2% against the peers' median +9%. Operating margin: 16.7% against the peers' median 16.4%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ALGN Align Technology | Q3 2026 | $1.0B | +2% | 16.7% |
| ISRG Intuitive Surgical | Q3 2026 | $3.0B | +22% | 19.4% |
| ZBH Zimmer Biomet Holdings | Q3 2026 | $2.1B | +3% | 14.9% |
| EW Edwards Lifesciences | Q3 2026 | $1.7B | +10% | 17.4% |
| STE Steris | Q2 FY27 | $1.6B | +9% | 18.5% |
| ENOV Enovis | Q3 2026 | $559M | +2% | 0.6% |
| MSA MSA Safety | Q3 2026 | $536M | +14% | 16.4% |
| CDRE Cadre Holdings | Q3 2026 | $203M | +30% | 14.0% |
| INGN Inogen | Q2 2026 | $95.1M | +3% | -5.4% |
Source: Align Technology 10-Q on SEC EDGAR · CIK 1097149 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Guidance and outlook
13F: who owns ALGN and who is buying
More on ALGN
- How Align Technology makes money: revenue by segment
- Align Technology next earnings date and what analysts expect
- Align Technology stock forecast, price target and fair value
- Who owns Align Technology stock: holders, funds and Congress trades
- Align Technology guidance and outlook
- Is Align Technology a takeover target? LBO and rumors
- Align Technology recalls, complaints and regulation
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Align Technology guidance history: guided vs reported
- Align Technology gross margin by quarter
- Align Technology operating margin by quarter
- Align Technology net income by quarter
- Align Technology free cash flow by quarter
- Align Technology R&D spending by quarter
- Align Technology capital expenditures by quarter